Cargando…

The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers

The tumour microenvironment consists of malignant cells, stroma, and immune cells. The role of adaptive immunity in inducing a pathological complete response (pCR) in breast cancer with neoadjuvant chemotherapy (NAC) is well studied. The contribution of innate immunity, however, is poorly documented...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaewkangsadan, Viriya, Verma, Chandan, Eremin, Jennifer M., Cowley, Gerard, Ilyas, Mohammad, Satthaporn, Sukchai, Eremin, Oleg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587972/
https://www.ncbi.nlm.nih.gov/pubmed/28913366
http://dx.doi.org/10.1155/2017/1049023
_version_ 1783262095289090048
author Kaewkangsadan, Viriya
Verma, Chandan
Eremin, Jennifer M.
Cowley, Gerard
Ilyas, Mohammad
Satthaporn, Sukchai
Eremin, Oleg
author_facet Kaewkangsadan, Viriya
Verma, Chandan
Eremin, Jennifer M.
Cowley, Gerard
Ilyas, Mohammad
Satthaporn, Sukchai
Eremin, Oleg
author_sort Kaewkangsadan, Viriya
collection PubMed
description The tumour microenvironment consists of malignant cells, stroma, and immune cells. The role of adaptive immunity in inducing a pathological complete response (pCR) in breast cancer with neoadjuvant chemotherapy (NAC) is well studied. The contribution of innate immunity, however, is poorly documented. Breast tumours and axillary lymph nodes (ALNs) from 33 women with large and locally advanced breast cancers (LLABCs) undergoing NAC were immunohistochemically assessed for tumour-infiltrating macrophages (TIMs: M1 and M2), neutrophils (TINs), and dendritic cells (TIDCs) using labelled antibodies and semiquantitative methods. Patients' blood neutrophils (n = 108), DCs (mDC1 and pDC), and their costimulatory molecules (n = 30) were also studied. Pathological results were classified as pCR, good (GPR) or poor (PRR). In breast and metastatic ALNs, high levels of CD163(+) TIMs were significantly associated with a pCR. In blood, high levels of neutrophils were significantly associated with pCR in metastatic ALNs, whilst the % of mDC1 and pDC and expression of HLA-DR, mDC1 CD40, and CD83 were significantly reduced. NAC significantly reduced tumour DCs but increased blood DCs. PPRs to NAC had significantly reduced HLA-DR, CD40, and CD86 expression. Our study demonstrated novel findings documenting the differential but important contributions of innate immunity to pCRs in patients with LLABCs undergoing NAC.
format Online
Article
Text
id pubmed-5587972
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-55879722017-09-14 The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers Kaewkangsadan, Viriya Verma, Chandan Eremin, Jennifer M. Cowley, Gerard Ilyas, Mohammad Satthaporn, Sukchai Eremin, Oleg J Immunol Res Research Article The tumour microenvironment consists of malignant cells, stroma, and immune cells. The role of adaptive immunity in inducing a pathological complete response (pCR) in breast cancer with neoadjuvant chemotherapy (NAC) is well studied. The contribution of innate immunity, however, is poorly documented. Breast tumours and axillary lymph nodes (ALNs) from 33 women with large and locally advanced breast cancers (LLABCs) undergoing NAC were immunohistochemically assessed for tumour-infiltrating macrophages (TIMs: M1 and M2), neutrophils (TINs), and dendritic cells (TIDCs) using labelled antibodies and semiquantitative methods. Patients' blood neutrophils (n = 108), DCs (mDC1 and pDC), and their costimulatory molecules (n = 30) were also studied. Pathological results were classified as pCR, good (GPR) or poor (PRR). In breast and metastatic ALNs, high levels of CD163(+) TIMs were significantly associated with a pCR. In blood, high levels of neutrophils were significantly associated with pCR in metastatic ALNs, whilst the % of mDC1 and pDC and expression of HLA-DR, mDC1 CD40, and CD83 were significantly reduced. NAC significantly reduced tumour DCs but increased blood DCs. PPRs to NAC had significantly reduced HLA-DR, CD40, and CD86 expression. Our study demonstrated novel findings documenting the differential but important contributions of innate immunity to pCRs in patients with LLABCs undergoing NAC. Hindawi 2017 2017-08-23 /pmc/articles/PMC5587972/ /pubmed/28913366 http://dx.doi.org/10.1155/2017/1049023 Text en Copyright © 2017 Viriya Kaewkangsadan et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kaewkangsadan, Viriya
Verma, Chandan
Eremin, Jennifer M.
Cowley, Gerard
Ilyas, Mohammad
Satthaporn, Sukchai
Eremin, Oleg
The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers
title The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers
title_full The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers
title_fullStr The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers
title_full_unstemmed The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers
title_short The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers
title_sort differential contribution of the innate immune system to a good pathological response in the breast and axillary lymph nodes induced by neoadjuvant chemotherapy in women with large and locally advanced breast cancers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587972/
https://www.ncbi.nlm.nih.gov/pubmed/28913366
http://dx.doi.org/10.1155/2017/1049023
work_keys_str_mv AT kaewkangsadanviriya thedifferentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT vermachandan thedifferentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT ereminjenniferm thedifferentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT cowleygerard thedifferentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT ilyasmohammad thedifferentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT satthapornsukchai thedifferentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT ereminoleg thedifferentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT kaewkangsadanviriya differentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT vermachandan differentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT ereminjenniferm differentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT cowleygerard differentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT ilyasmohammad differentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT satthapornsukchai differentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers
AT ereminoleg differentialcontributionoftheinnateimmunesystemtoagoodpathologicalresponseinthebreastandaxillarylymphnodesinducedbyneoadjuvantchemotherapyinwomenwithlargeandlocallyadvancedbreastcancers